APCR Issues Statement on COVID-19

Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research




News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971
John.lezcano@informa.com
pharmaintelligence.informa.com

venBio Raises $394m To Fund Biopharmas Through Human Proof-Of-Concept

Fri, 04/03/2020 - 1:52pm

Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors...

      Related Stories 

Asia Deal Watch: Daiichi Sankyo Pays $200m To Ultragenyx For AAV Technology Access

Fri, 04/03/2020 - 6:41am

A busy stretch of deal-making across Asia all includes transactions involving Innovent, Alector, Ono, Numab, Alphamab, 3DMed, Healios, Athersys, Laekna...

      Related Stories 

Coronavirus Update: Novartis Targets COVID-19 Cytokine Storm With Jakavi

Fri, 04/03/2020 - 12:43am

Jakavi joins the likes of Actemra in targeting the life-threatening immune reaction which is killing acutely ill COVID-19 patients

      Related Stories 

Flagship, ARCH Close VC Funds Totaling $2.56bn

Thu, 04/02/2020 - 4:18pm

Flagship Pioneering raised $1.1bn to fund life science companies emerging from Flagship Labs. ARCH, another frequent start-up co-founder, raised two...

      Related Stories 

Amgen, Adaptive Partner In COVID-19 Neutralizing Antibody R&D Effort

Thu, 04/02/2020 - 2:18pm

The companies are combining their technologies to seek neutralizing antibody therapeutics that could prevent or treat COVID-19, building on their...

      Related Stories 

Interview: iTeos Attracts Investors By Targeting TIGIT

Thu, 04/02/2020 - 7:20am

The Belgian biotech has managed to attract considerable sums from venture capitalists over the past couple of years amid hopes...

      Related Stories 

Jubilant Sees No Material Impact From Coronavirus-Led Plant Closure, For Now

Thu, 04/02/2020 - 12:59am

Jubilant Life Sciences anticipates continued strong demand despite temporary logistics blips in India and expects to resume operations at its...

      Related Stories 

Aurobindo-Sandoz End $1bn US Deal

Thu, 04/02/2020 - 12:27am

Aurobindo and Sandoz mutually terminate their planned $1bn deal, leaving many questions on how both sides will re-orient strategies going...

      Related Stories 

Takeda Gets New India Chief, Mandate To Broaden Access

Wed, 04/01/2020 - 5:33pm

Takeda appoints new country head for India and aims to improve patient access to innovative medicines in the largely out-of-pocket...

      Related Stories 

Finance Watch: iTeos, Pandion And Aspen Show COVID-19 Hasn’t Slowed VC Deals Yet

Wed, 04/01/2020 - 2:04pm

Aspen Neuroscience, Pandion and iTeos raised $70m, $80m and $125m, respectively. Also, Glide Healthcare closed a €416m ($450m) fund; ElevateBio...

      Related Stories 

Global AMR R&D Hub launches Dynamic Data Dashboard

Wed, 04/01/2020 - 9:26am

The Global AMR R&D Hub’s newly launched Dynamic Dashboard aims to be “a comprehensive knowledge center for AMR R&D and...

      Related Stories 

Exscientia Links With Scripp Research’s Calibr To Apply AI To COVID-19

Wed, 04/01/2020 - 7:41am

A transatlantic initiative is screening a US library of 15,000 pharmacologically active compounds for anti-COVID-19 activity, using artificial intelligence technologies...

      Related Stories 

Interview: Arvelle Aims To Be Major Player In CNS

Wed, 04/01/2020 - 4:04am

The Swiss biotech's focal-onset seizure therapy, which is licensed from South Korea's SK and is already approved in the US...

      Related Stories 

Pages